A Long Term Study of SPP100 in Patients With Essential Hypertension (Trial is Not Recruiting in the US)

Long-Term Treatment, Multicenter, Open-Label Study With SPP100 in Patients With Essential Hypertension

This study will evaluate the safety and efficacy of long term treatment of SPP100 in patients with essential hypertension. (Trial is not recruiting in the US)

Inclusion Criteria:

• Diagnosed as essential hypertension -

Exclusion Criteria:

• Patients with secondary hypertension or suspected of having secondary hypertension.
• Patients suspected of having malignant hypertension
• Patients with any serious diseases or symptoms